CRIS Current Research Information System

GIONCHETTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.185
AS - Asia 13.908
EU - Europa 10.007
SA - Sud America 937
AF - Africa 918
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 40.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.885
SG - Singapore 3.744
VN - Vietnam 3.701
CN - Cina 3.318
IT - Italia 2.164
GB - Regno Unito 2.018
DE - Germania 1.223
SE - Svezia 1.058
HK - Hong Kong 1.012
FR - Francia 707
BR - Brasile 693
IN - India 594
RU - Federazione Russa 574
UA - Ucraina 449
IE - Irlanda 410
KR - Corea 344
FI - Finlandia 322
NL - Olanda 289
JP - Giappone 275
ZA - Sudafrica 221
CI - Costa d'Avorio 207
BD - Bangladesh 194
TG - Togo 174
SC - Seychelles 163
CH - Svizzera 145
BG - Bulgaria 138
CA - Canada 130
EE - Estonia 130
JO - Giordania 120
AR - Argentina 115
PH - Filippine 98
BE - Belgio 74
MX - Messico 67
PL - Polonia 66
ID - Indonesia 64
IQ - Iraq 64
TH - Thailandia 59
ES - Italia 57
AT - Austria 54
TW - Taiwan 44
HN - Honduras 41
TR - Turchia 41
GR - Grecia 33
IR - Iran 32
SA - Arabia Saudita 31
EC - Ecuador 30
NG - Nigeria 29
CD - Congo 27
PK - Pakistan 27
UZ - Uzbekistan 27
CL - Cile 25
CO - Colombia 24
PY - Paraguay 19
AU - Australia 17
BZ - Belize 17
EG - Egitto 16
KZ - Kazakistan 16
LT - Lituania 15
RO - Romania 15
VE - Venezuela 15
CZ - Repubblica Ceca 14
KE - Kenya 14
JM - Giamaica 13
TN - Tunisia 13
AZ - Azerbaigian 12
HR - Croazia 12
MY - Malesia 12
AE - Emirati Arabi Uniti 11
LB - Libano 11
MA - Marocco 11
DZ - Algeria 10
ET - Etiopia 10
AL - Albania 8
BH - Bahrain 8
BO - Bolivia 7
IL - Israele 7
PS - Palestinian Territory 7
DO - Repubblica Dominicana 6
CR - Costa Rica 5
PE - Perù 5
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BF - Burkina Faso 4
DK - Danimarca 4
MD - Moldavia 4
MN - Mongolia 4
NP - Nepal 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AO - Angola 3
BB - Barbados 3
CY - Cipro 3
KG - Kirghizistan 3
NO - Norvegia 3
PT - Portogallo 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AG - Antigua e Barbuda 2
Totale 40.927
Salva come PNG Salva come JPEG
Città #
Singapore 2.558
Ashburn 1.682
Southend 1.642
Fairfield 1.282
Chandler 1.042
Hong Kong 961
San Jose 900
Ho Chi Minh City 826
Hanoi 716
Hefei 708
Santa Clara 672
Woodbridge 616
Houston 542
Seattle 542
Wilmington 538
Princeton 515
Dong Ket 444
Beijing 435
Cambridge 419
Dublin 409
Bologna 406
Ann Arbor 353
Boardman 327
Lauterbourg 297
Seoul 292
New York 278
Helsinki 273
Los Angeles 253
Jacksonville 249
Tokyo 229
Abidjan 207
Nanjing 201
Council Bluffs 199
Lomé 174
Westminster 174
Berlin 168
Milan 167
Padova 153
Frankfurt am Main 140
Buffalo 139
Sofia 133
Bern 121
Dallas 121
Amman 120
Da Nang 116
Haiphong 110
São Paulo 107
San Diego 106
Rome 92
Guangzhou 89
Redondo Beach 87
Turin 82
Bengaluru 80
Jinan 80
Shenyang 80
Saint Petersburg 76
Phoenix 72
Changsha 70
Brescia 65
Johannesburg 62
Hebei 60
Munich 60
Chicago 58
Shanghai 58
London 56
Nuremberg 55
Washington 53
Brussels 52
Redwood City 52
Mülheim 51
Yubileyny 51
Nanchang 50
Orem 49
Falkenstein 48
Montreal 44
Medford 42
Redmond 42
San Francisco 42
Bremen 41
Atlanta 40
Florence 40
Tianjin 40
Hải Dương 39
Warsaw 38
Dearborn 36
Quận Bình Thạnh 36
Des Moines 35
Henderson 34
Jiaxing 34
Thái Nguyên 34
Falls Church 33
Zhengzhou 33
Lappeenranta 32
Mexico City 32
Amsterdam 31
Biên Hòa 31
Hangzhou 30
Boston 29
Mahé 29
Olalla 29
Totale 25.676
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 678
Ulcerative Colitis 372
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 359
COVID-19 in IBD: The experience of a single tertiary IBD center 306
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 301
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 275
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment 262
A Heavy Feeling in the Stomach: Neural Correlates of Anxiety in Crohn's Disease 258
Adult attachment and early parental experiences in patients with Crohn’s Disease 258
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 255
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 246
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 244
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 243
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 240
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. 238
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 236
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 235
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 232
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 227
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 224
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 223
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 222
Medical treatment and management of severe ulcerative colitis 221
Infliximab in the treatment of Crohn's disease 217
Adalimumab in active ulcerative colitis: a "real-life" observational study. 215
Attachment and quality of life in patients with inflammatory bowel disease 215
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 214
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 214
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 211
High-dose probiotics for the treatment of active pouchitis 210
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 210
Influence of steroid treatment's duration in patients with active Crohn's disease 206
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 200
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 199
Adalimumab Clearance, rather than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically 198
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 198
Implications of the westernized diet in the onset and progression of IBD 198
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease 197
Percutaneous Drainage vs. Surgery as Definitive Treatment for Anastomotic Leak after Intestinal Resection in Patients with Crohn's Disease 196
Implications of antioxidant enzymes in human gastric neoplasms 195
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 194
Clinical course of microscopic colitis in a single-center cohort study 193
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 192
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 192
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 192
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 191
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 190
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 190
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. 188
Antibiotics and probiotics in treatment of inflammatory bowel disease 188
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 187
Management and treatment of distal ulcerative colitis 187
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 187
Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches 187
Oral budesonide in the treatment of chronic refractory pouchitis. 186
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management 186
Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts 185
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 182
Review article: aminosalicylates for distal colitis 182
P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era 182
Post COVID-19 irritable bowel syndrome 181
Management of inflammatory bowel disease: does rifaximin offer any promises 181
Role of conventional therapies in the era of biological treatment in Crohn's disease. 181
Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages 180
Parental Bonding and Inflammatory Bowel Disease 180
Probiotics in IBD: A critical review 180
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients 180
Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. 179
Clinical guidelines for the management of pouchitis 179
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 178
Role of Biologics in refractory pouchitis 178
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 177
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 177
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment 176
Percutaneous abdomino-pelvic abscess drainage in complicated Crohn’s disease 176
MANAGEMENT OF POUCHITIS 175
The role of Budesonide-MMX in active ulcerative colitis. 174
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 173
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 172
Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocaecal resection for Crohn's disease: A retrospective analysis of 853 consecutive patients 171
Which therapies are advisable in pouchitis? 170
Antimicrobials in the management of inflammatory bowel disease 170
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 169
Pre-pouch ileitis 169
P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years 169
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease 168
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 168
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 167
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 166
Risks and Benefits of Mucosal Healing With Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic That Needs Careful Evaluation 165
Sympathetic hyperactivity in patients with ulcerative colitis. 164
Randomized controlled trials in pouchitis 164
Transabdominal salvage surgery after pouch failure in a tertiary center: a case-matched study 164
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 164
A current overview of corticosteroid use in active ulcerative colitis 164
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 163
Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn’s Disease 163
Oral beclomethasone dipropionate in chronic refractory pouchitis 162
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 162
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 162
Totale 20.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.233
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021848 0 0 0 0 0 0 0 0 0 0 0 848
2021/20224.114 431 114 247 182 332 178 98 227 331 293 1.079 602
2022/20234.892 505 745 248 551 319 387 141 286 898 141 340 331
2023/20241.530 107 237 137 111 125 358 78 91 40 110 60 76
2024/20255.994 296 834 478 382 929 305 447 208 142 408 318 1.247
2025/202615.516 1.385 1.564 1.335 1.084 1.580 936 1.594 530 2.964 1.381 687 476
Totale 41.909